Institut Gustave Roussy; Drct

Villejuif 94805

0 studies enrolling now · 1 studies all time

What they study most

Hematologic Malignancies, Tumors

Studies at this site

• A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tolerability and Pharmacokinetics in Participants With Locally Advanced or Metastatic Solid Tumors — Completed